1.Pillai S: T and B lymphocytes in fibrosis and systemic sclerosis.Curr Opin Rheumatol 2019, 31:576-581.
2.Shi X, Liu Q, Zhao H, Lu J, Huang Y, Ma Y, Xia J, Liu M, Tu W, Jin L, et al: Increased expression of GAB1 promotes inflammation and fibrosis in systemic sclerosis.Exp Dermatol 2019.
3.Henry TW, Mendoza FA, Jimenez SA: Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy.Autoimmun Rev 2019:102396.
4.Di Benedetto P, Ruscitti P, Liakouli V, Cipriani P, Giacomelli R: The Vessels Contribute to Fibrosis in Systemic Sclerosis.Isr Med Assoc J 2019, 21:471-474.
5.Trojanowska M: Cellular and molecular aspects of vascular dysfunction in systemic sclerosis.Nat Rev Rheumatol 2010, 6:453-460.
6.Jun JB, Kuechle M, Harlan JM, Elkon KB: Fibroblast and endothelial apoptosis in systemic sclerosis.Curr Opin Rheumatol 2003, 15:756-760.
7.Yang X, Yang J, Xing X, Wan L, Li M: Increased frequency of Th17 cells in systemic sclerosis is related to disease activity and collagen overproduction.Arthritis Res Ther 2014, 16:R4.
8.Xing X, Yang J, Yang X, Wei Y, Zhu L, Gao D, Li M: IL-17A induces endothelial inflammation in systemic sclerosis via the ERK signaling pathway.Plos One 2013, 8:e85032.
9.Liu M, Yang J, Xing X, Cui X, Li M: Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway.Arthritis Res Ther 2014, 16:4223.
10.Liu M, Yang J, Li M: Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway.Clinics (Sao Paulo) 2015, 70:250-256.
11.Liu M, Wu W, Sun X, Yang J, Xu J, Fu W, Li M: New insights into CD4(+) T cell abnormalities in systemic sclerosis.Cytokine Growth Factor Rev 2016, 28:31-36.
12.Guggino G, Lo PM, Di Liberto D, Rizzo A, Cipriani P, Ruscitti P, Candore G, Gambino CM, Sireci G, Dieli F, et al: Interleukin-9 over-expression and T helper 9 polarization in systemic sclerosis patients.Clin Exp Immunol 2017, 190:208-216.
13.Ciccia F, Guggino G, Ferrante A, Cipriani P, Giacomelli R, Triolo G: Interleukin-9 and T helper type 9 cells in rheumatic diseases.Clin Exp Immunol 2016, 185:125-132.
14.Nowak EC, Weaver CT, Turner H, Begum-Haque S, Becher B, Schreiner B, Coyle AJ, Kasper LH, Noelle RJ: IL-9 as a mediator of Th17-driven inflammatory disease.J Exp Med 2009, 206:1653-1660.
15.Elyaman W, Bradshaw EM, Uyttenhove C, Dardalhon V, Awasthi A, Imitola J, Bettelli E, Oukka M, van Snick J, Renauld JC, et al: IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells.Proc Natl Acad Sci U S A 2009, 106:12885-12890.
16.Li J, Chen S, Xiao X, Zhao Y, Ding W, Li XC: IL-9 and Th9 cells in health and diseases-From tolerance to immunopathology.Cytokine Growth Factor Rev 2017, 37:47-55.
17.De Smedt M, Verhasselt B, Kerre T, Vanhecke D, Naessens E, Leclercq G, Renauld JC, Van Snick J, Plum J: Signals from the IL-9 receptor are critical for the early stages of human intrathymic T cell development.J Immunol 2000, 164:1761-1767.
18.Kerzerho J, Maazi H, Speak AO, Szely N, Lombardi V, Khoo B, Geryak S, Lam J, Soroosh P, Van Snick J, Akbari O: Programmed cell death ligand 2 regulates TH9 differentiation and induction of chronic airway hyperreactivity.J Allergy Clin Immunol 2013, 131:1048-1057, 1051-1057.
19.Nalleweg N, Chiriac MT, Podstawa E, Lehmann C, Rau TT, Atreya R, Krauss E, Hundorfean G, Fichtner-Feigl S, Hartmann A, et al: IL-9 and its receptor are predominantly involved in the pathogenesis of UC.Gut 2015, 64:743-755.
20.Weigmann B, Neurath MF: Th9 cells in inflammatory bowel diseases.Semin Immunopathol 2017, 39:89-95.
21.Elyaman W, Khoury SJ: Th9 cells in the pathogenesis of EAE and multiple sclerosis.Semin Immunopathol 2017, 39:79-87.
22.Angkasekwinai P: Allergic Inflammation and Atopic Disease: Role of Th9 Cells.Methods Mol Biol 2017, 1585:189-199.
23.Pinto M, Licona-Limon P: Th9 Cells and Parasitic Inflammation: Use of Nippostrongylus and Schistosoma Models.Methods Mol Biol 2017, 1585:223-245.